408 related articles for article (PubMed ID: 26709240)
1. The role of targeted prophylactic antimicrobial therapy before transrectal ultrasonography-guided prostate biopsy in reducing infection rates: a systematic review.
Cussans A; Somani BK; Basarab A; Dudderidge TJ
BJU Int; 2016 May; 117(5):725-31. PubMed ID: 26709240
[TBL] [Abstract][Full Text] [Related]
2. Targeted antimicrobial prophylaxis for transrectal ultrasound-guided prostate biopsy during active surveillance: Effect on hospitalization.
Cheung C; Patel HD; Landis P; Carter HB; Han M
Urol Oncol; 2018 Apr; 36(4):158.e7-158.e12. PubMed ID: 29288004
[TBL] [Abstract][Full Text] [Related]
3. Povidone-iodine rectal cleansing and targeted antimicrobial prophylaxis using rectal swab cultures in men undergoing transrectal ultrasound-guided prostate biopsy are associated with reduced incidence of postoperative infectious complications.
Ryu JW; Jung SI; Ahn JH; Hwang EC; Yu HS; Kang TW; Kwon DD; Park K; Kim JW
Int Urol Nephrol; 2016 Nov; 48(11):1763-1770. PubMed ID: 27495324
[TBL] [Abstract][Full Text] [Related]
4. Targeted Antimicrobial Prophylaxis Does Not Always Prevent Sepsis after Transrectal Prostate Biopsy.
Jiang P; Liss MA; Szabo RJ
J Urol; 2018 Aug; 200(2):361-368. PubMed ID: 29574110
[TBL] [Abstract][Full Text] [Related]
5. Ciprofloxacin resistance in the faecal carriage of patients undergoing transrectal ultrasound guided prostate biopsy.
Taylor S; Margolick J; Abughosh Z; Goldenberg SL; Lange D; Bowie WR; Bell R; Roscoe D; Machan L; Black P
BJU Int; 2013 May; 111(6):946-53. PubMed ID: 23464844
[TBL] [Abstract][Full Text] [Related]
6. The effectiveness of targeted relative to empiric prophylaxis on infectious complications after transrectal ultrasound-guided prostate biopsy: a meta-analysis.
Scott S; Harris PN; Williamson DA; Liss MA; Doi SAR; Roberts MJ
World J Urol; 2018 Jul; 36(7):1007-1017. PubMed ID: 29453690
[TBL] [Abstract][Full Text] [Related]
7. Baseline prevalence of antimicrobial resistance and subsequent infection following prostate biopsy using empirical or altered prophylaxis: A bias-adjusted meta-analysis.
Roberts MJ; Williamson DA; Hadway P; Doi SA; Gardiner RA; Paterson DL
Int J Antimicrob Agents; 2014 Apr; 43(4):301-9. PubMed ID: 24630305
[TBL] [Abstract][Full Text] [Related]
8. Targeted antimicrobial prophylaxis using rectal swab cultures in men undergoing transrectal ultrasound guided prostate biopsy is associated with reduced incidence of postoperative infectious complications and cost of care.
Taylor AK; Zembower TR; Nadler RB; Scheetz MH; Cashy JP; Bowen D; Murphy AB; Dielubanza E; Schaeffer AJ
J Urol; 2012 Apr; 187(4):1275-9. PubMed ID: 22341272
[TBL] [Abstract][Full Text] [Related]
9. An antimicrobial prophylaxis protocol using rectal swab cultures for transrectal prostate biopsy.
Summers SJ; Patel DP; Hamilton BD; Presson AP; Fisher MA; Lowrance WT; Southwick AW
World J Urol; 2015 Dec; 33(12):2001-7. PubMed ID: 25935330
[TBL] [Abstract][Full Text] [Related]
10. A prospective randomized comparative study of targeted versus empirical prophylactic antibiotics in the prevention of infective complications following transrectal ultrasound-guided prostate biopsy.
Doherty AF; Ikuerowo SO; Jeje EA; Ibrahim NA; Ojongbede OL; Mutiu WB; Omisanjo OA; Abolarinwa AA
Ann Afr Med; 2019; 18(3):132-137. PubMed ID: 31417013
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of culture-guided antimicrobial prophylaxis for the prevention of infections after prostate biopsy.
Li CK; Tong BCY; You JHS
Int J Infect Dis; 2016 Feb; 43():7-12. PubMed ID: 26686941
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of fluoroquinolone-resistant rectal flora in patients undergoing transrectal ultrasound-guided prostate needle biopsy: A prospective multicenter study.
Chung HS; Hwang EC; Yu HS; Jung SI; Lee SJ; Lim DH; Cho WJ; Choe HS; Lee SJ; Park SW
Int J Urol; 2018 Mar; 25(3):278-283. PubMed ID: 29241300
[TBL] [Abstract][Full Text] [Related]
13. "Targeted" prophylaxis: Impact of rectal swab culture-directed prophylaxis on infectious complications after transrectal ultrasound-guided prostate biopsy.
Singh P; Kumar A; Yadav S; Prakash L; Nayak B; Kumar R; Kapil A; Dogra PN
Investig Clin Urol; 2017 Sep; 58(5):365-370. PubMed ID: 28868509
[TBL] [Abstract][Full Text] [Related]
14. Effect of Augmented Antimicrobial Prophylaxis and Rectal Swab Culture-guided Targeted Prophylaxis on the Risk of Sepsis Following Transrectal Prostate Biopsy.
Hadjipavlou M; Eragat M; Kenny C; Pantelidou M; Mulhem W; Wood C; Dall'Antonia M; Hammadeh MY
Eur Urol Focus; 2020 Jan; 6(1):95-101. PubMed ID: 31928632
[TBL] [Abstract][Full Text] [Related]
15. Fluoroquinolone-resistant Escherichia coli among the rectal flora is the predominant risk factor for severe infection after transrectal ultrasound-guided prostate biopsy: a prospective observational study.
Holmbom M; Forsberg J; Fredrikson M; Nilsson M; Nilsson LE; Hanberger H; Hällgren A
Scand J Urol; 2023 Aug; 58():32-37. PubMed ID: 37553957
[TBL] [Abstract][Full Text] [Related]
16. Rectal cultures before transrectal ultrasound-guided prostate biopsy reduce post-prostatic biopsy infection rates.
Duplessis CA; Bavaro M; Simons MP; Marguet C; Santomauro M; Auge B; Collard DA; Fierer J; Lesperance J
Urology; 2012 Mar; 79(3):556-61. PubMed ID: 22386395
[TBL] [Abstract][Full Text] [Related]
17. Preprostate Biopsy Rectal Culture and Postbiopsy Sepsis.
Taylor AK; Murphy AB
Urol Clin North Am; 2015 Nov; 42(4):449-58. PubMed ID: 26475942
[TBL] [Abstract][Full Text] [Related]
18. Selective culture of Escherichia coli to prevent infective complications of transrectal ultrasound-guided prostate biopsy: Clinical efficacy and analysis of characteristics of quinolone-resistant Escherichia coli.
Hiyama Y; Takahashi S; Uehara T; Ichihara K; Hashimoto J; Matsukawa M; Taguchi K; Kunishima Y; Hotta H; Yanase M; Itoh N; Hirose T; Takeyama K; Tachiki H; Masumori N
Int J Urol; 2019 Jun; 26(6):655-660. PubMed ID: 30959574
[TBL] [Abstract][Full Text] [Related]
19. Antibiotic susceptibility of intestinal Escherichia coli in men undergoing transrectal prostate biopsies: a prospective, registered, multicentre study.
Knaapila J; Kallio H; Hakanen AJ; Syvänen K; Ettala O; Kähkönen E; Lamminen T; Seppänen M; Jambor I; Rannikko A; Riikonen J; Munukka E; Eerola E; Gunell M; Boström PJ
BJU Int; 2018 Aug; 122(2):203-210. PubMed ID: 29533507
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness of standard vs intensive antibiotic regimens for transrectal ultrasonography (TRUS)-guided prostate biopsy prophylaxis.
Adibi M; Pearle MS; Lotan Y
BJU Int; 2012 Jul; 110(2 Pt 2):E86-91. PubMed ID: 22115356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
